Factual data · GO/NO-GO verdict · Financial model calibrated over 96 months
A pharmacy in San Antonio generates 1.6M USD-4.7M USD USD revenue, with net margin of 8 %. Typical mix: 75-85 % prescription drugs (regulated margin), 15-25 % OTC/wellness (free margin 35-45 %).
Dominant profile: residentielle · touristique
San Antonio (Texas, United States) has about 1.5M inhabitants and shows mostly residential fabric, proximity-driven demand, and strong tourist footfall boosting seasonal spending and average ticket. For a pharmacy project, this means a average average ticket and a setup cost close to the national average.
The market can still absorb a well-positioned entrant, provided a clear niche is targeted. Concretely, initial investment calibrated for San Antonio ranges from 840K USD to 3.7M USD, and Year 1 target revenue sits between 1.6M USD and 4.7M USD — a range that already factors in the local coefficients of this city (+5% vs average on costs, +5% vs average on purchasing power).
Competitive density: medium (clear niches still open).
Dominant players: regulated public-insurance sector, few private chains.
Positioning recommendation: Competitive positioning required: sector margin is tight, edge comes from operational efficiency.
| Indicator | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Year 1 revenue | 1.6M USD → 4.7M USD | ×1,18 (ramp-up) | ×1,32 (steady-state) |
| Target net margin | negative to low | 4 % | 10 % |
| Working capital (days of revenue) | 45-60 d | 35-50 d | 30-45 d |
| Cumulative ROI | investment | ~50 % | Payback at 96 months |
These ratios are calibrated on MarketLens sector benchmarks and adjusted by local coefficients of San Antonio, United States (cost +5% vs average, income +5% vs average).
This page combines multiple data sources for a factual analysis calibrated on San Antonio.
MarketLens combines AI market study, business plan calibrated for 24 countries, and post-launch monitoring. Everything exportable to PDF, PowerPoint, Excel and Word.